New 14,15-dinor--clerodane and -clerodane diterpenoids from Wall. ex benth.

One new diterpenoid possessing a rare 14,15-dinor--clerodane framework, ajugamacrin H (), and one new -clerodane diterpenoid, ajugamacrin I (), along with seven known analogues (-), were obtained from Wall. ex Benth..

Association of Overlapped and Un-overlapped Comorbidities with COVID-19 Severity and Treatment Outcomes: A Retrospective Cohort Study from Nine Provinces in China.

Objective: Several COVID-19 patients have overlapping comorbidities. The independent role of each component contributing to the risk of COVID-19 is unknown, and how some non-cardiometabolic comorbidities affect the risk of COVID-19 remains unclear.

Methods: A retrospective follow-up design was adopted.